Latest news with #TCI
Yahoo
a day ago
- Business
- Yahoo
Transcontinental Realty Investors Second Quarter 2025 Earnings: EPS: US$0.02 (vs US$0.17 in 2Q 2024)
Explore Transcontinental Realty Investors's Fair Values from the Community and select yours Transcontinental Realty Investors (NYSE:TCI) Second Quarter 2025 Results Key Financial Results Revenue: US$12.2m (up 2.3% from 2Q 2024). Net income: US$169.0k (down 89% from 2Q 2024). Profit margin: 1.4% (down from 13% in 2Q 2024). EPS: US$0.02 (down from US$0.17 in 2Q 2024). We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. All figures shown in the chart above are for the trailing 12 month (TTM) period Transcontinental Realty Investors shares are up 4.7% from a week ago. Risk Analysis We should say that we've discovered 1 warning sign for Transcontinental Realty Investors that you should be aware of before investing here. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
San Francisco Chronicle
3 days ago
- Business
- San Francisco Chronicle
Transcontinental Realty: Q2 Earnings Snapshot
DALLAS (AP) — DALLAS (AP) — Transcontinental Realty Investors Inc. (TCI) on Thursday reported net income of $169,000 in its second quarter. On a per-share basis, the Dallas-based company said it had profit of 2 cents. The real estate investor posted revenue of $12.2 million in the period. _____
Yahoo
3 days ago
- Business
- Yahoo
Transcontinental Realty Investors, Inc. reports Earnings for Quarter Ended June 30, 2025
DALLAS, August 07, 2025--(BUSINESS WIRE)--Transcontinental Realty Investors, Inc. (NYSE:TCI) is reporting its results of operations for the three months ended June 30, 2025. For the three months ended June 30, 2025, we reported net income attributable to common shares of $0.2 million or $0.02 per diluted share, compared to $1.5 million or $0.17 per diluted share for the same period in 2024. Financial Highlights Total occupancy was 82% at June 30, 2025, which includes 94% at our multifamily properties and 57% at our commercial properties. During the three months ended June 30, 2025, we sold 30 single family lots from our holdings in Windmill Farms for $1.4 million, resulting in a gain on sale of $1.1 million. On May 30, 2025, we paid off the $10.8 million loan on 770 South Post Oak with cash on hand. Financial Results Rental revenues increased $0.3 million from $11.2 million for the three months ended June 30, 2024 to $11.5 million for the three months ended June 30, 2025. The increase in rental revenue is primarily due to an increase in occupancy at Stanford Center. Net operating loss decreased $0.3 million from $1.1 million for the three months ended June 30, 2024 to $0.8 million for the three months ended June 30, 2025. Our decrease in net operating loss was due to a $0.1 million decrease in operating expenses. The decrease in operating expenses is primarily due to a decrease in the cost of insurance and property taxes for the three months ended June 30, 2025. Net income attributable to the Company decreased $1.3 million from $1.5 million for the three months ended June 30, 2024 to $0.2 million for the three months ended June 30, 2025. The decrease in net income is primarily attributed to a decrease in interest income and an increase in tax provision for the three months ended June 30, 2025 offset in part by an increase in gain on real estate transactions. About Transcontinental Realty Investors, Inc. Transcontinental Realty Investors, Inc., a Dallas-based real estate investment company, holds a diverse portfolio of equity real estate located across the U.S., including office buildings, apartments, shopping centers, and developed and undeveloped land. The Company invests in real estate through direct ownership, leases and partnerships and invests in mortgage loans on real estate. The Company also holds mortgage receivables. TRANSCONTINENTAL REALTY INVESTORS, INC. CONSOLIDATED STATEMENTS OF OPERATIONS (Dollars in thousands, except per share amounts) (Unaudited) Three Months EndedJune 30, Six Months EndedJune 30, 2025 2024 2025 2024 Revenues: Rental revenues $ 11,510 $ 11,188 $ 22,937 $ 22,467 Other income 650 585 1,231 1,205 Total revenue 12,160 11,773 24,168 23,672 Expenses: Property operating expenses 6,535 6,624 12,512 13,258 Depreciation and amortization 3,062 3,137 5,945 6,309 General and administrative 1,383 1,414 2,735 2,675 Advisory fee to related party 2,005 1,680 4,436 3,845 Total operating expenses 12,985 12,855 25,628 26,087 Net operating loss (825 ) (1,082 ) (1,460 ) (2,415 ) Interest income 3,982 5,200 8,610 11,327 Interest expense (1,738 ) (1,862 ) (3,519 ) (3,731 ) Equity in income from unconsolidated joint venture - 109 - 544 Gain on sale or write-down of assets, net 947 - 4,838 - Income tax provision (2,042 ) (669 ) (3,364 ) (1,272 ) Net income 324 1,696 5,105 4,453 Net income attributable to noncontrolling interest (155 ) (198 ) (318 ) (406 ) Net income attributable to the Company $ 169 $ 1,498 $ 4,787 $ 4,047 Earnings per share Basic and diluted $ 0.02 $ 0.17 $ 0.55 $ 0.47 Weighted average common shares used in computing earnings per share Basic and diluted 8,639,316 8,639,316 8,639,316 8,639,316 View source version on Contacts Transcontinental Realty Investors, Inc. Investor RelationsErik Johnson (469)
News18
28-07-2025
- Business
- News18
Transport Corporation of India reports 19 pc rise in PAT to Rs 124 cr in Q1
Agency: PTI Last Updated: Mumbai, Jul 28 (PTI) Multimodal logistics operator Transport Corporation of India (TCI) on Monday reported 19 per cent growth in standalone profit after tax (PAT) at Rs 124.2 crore in the June quarter. The company, in a statement, said it had posted standalone PAT of Rs 104.7 crore in the year-ago period. Revenue during the quarter under review stood at Rs 1,033.8 crore from Rs 984 crore, registering a growth of 5.1 per cent year-on-year, it said. The company also said it delivered earnings before interest, taxes, depreciation and amortisation (EBITDA) of Rs 162.9 crore during the April-June period, as against Rs 144.7 crore in the first quarter of FY25. 'We have delivered solid progress in the first quarter of FY�26, driven by steady growth across our multimodal, warehousing, third-party logistics and cold chain verticals. Despite mixed sectoral trends in the economy, our integrated service offerings and customer-centric approach have enabled us to maintain noteworthy operational momentum," TCI Managing Director Vineet Agarwal said. According to Agarwal, the manufacturing sector's revival, particularly in chemicals, engineering and consumer goods, has positively impacted demand for reliable, scalable and sustainable logistics solutions. TCI's continued investments in multimodal infrastructure, upskilling, AI-based SOPs and green logistics have positioned the company well to deliver the diverse supply chain solutions that meet the scale of India's evolving logistics requirements, he said. The company anticipates a robust order pipeline in the coming quarters, with continued infrastructure push and steady influx of global players driving multifaceted manufacturing growth, he said. PTI IAS TRB view comments First Published: July 28, 2025, 17:00 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
The Hindu
14-07-2025
- Health
- The Hindu
The science behind TCI-TIVA — a safer, cleaner, smarter anaesthesia that is taking over operation theatres
Imagine entering a hospital for surgery — anxious about tubes, masks, gas machines, and how you'll feel afterward. But what if the anaesthesia could be clean, precise, and comfortable — without needing to inhale anything? Welcome to the silent revolution transforming operating rooms across India and the world: TCI-TIVA Target Controlled Infusion with Total Intra Venous Anaesthesia. Anaesthesia is the backbone of modern surgery. It makes painless operations possible, from small procedures to major life-saving surgeries. Traditionally, anaesthesia is given using gases through specialised machines. But a new, smarter method is rapidly taking its place — TIVA, or Total Intravenous Anaesthesia, especially when used with TCI, or Target-Controlled Infusion. This method is safer for patients and for the planet — and it's already changing lives in Indian hospitals. What is TCI-TIVA? In simple terms, TIVA means putting you to sleep using medicines injected through an intravenous (IV) line, instead of gases you inhale. TCI is a smart system that controls how these medicines are delivered. It uses computerised calculations and infusion pumps to maintain the exact level of sleep and comfort your body needs — adapting in real time. Think of it like an autopilot for anaesthesia — precise, responsive, and reliable. Why is this technique revolutionary? TCI aids in greater safety and accuracy. It uses advanced pharmacological models to calculate the right dose based on your body, age, and health status. This avoids issues like under- or over-dosing, unstable blood pressure, or delayed recovery. It also aids in faster and clearer recovery, with patients under TIVA often waking up faster, more alert, and with less nausea or vomiting. This is particularly beneficial for same-day surgeries or when you want to get back to normal quickly. From infants to the elderly, TIVA is gentle and effective. It doesn't rely on your lungs or airways, so it's safer for people with asthma, allergies, or lung issues. No gas also means no pollution: traditional anaesthesia uses gases that are released into the atmosphere after use. These gases are potent greenhouse contributors, some thousands of times more harmful than carbon dioxide. In contrast, TCI-TIVA does not release any gases, making it a green anaesthesia technique. It's safer for the planet — and cleaner for the surgical team and patient alike. Operating rooms using traditional gases contribute thousands of tons of greenhouse gases every year. One study estimated that replacing just one patient's gas-based anaesthesia with TCI-TIVA saved the equivalent of 500 km of car emissions. If even half the hospitals in India adopt this change, the environmental impact would be enormous. The science behind TCI-TIVA Modern TCI machines are highly advanced. They use real-time feedback from brain-monitoring tools like the BIS (Bispectral Index) by measuring and controlling anaesthesia depth. They deliver exact doses tailored to minute-by-minute needs. They also help reduce human error through safety alerts and pre-set drug libraries. TCI machines have touchscreen interfaces for user-friendly control by anaesthesia providers. This means better safety, quicker adjustments, and peace of mind for both doctors and patients. What medicines are used? TCI-TIVA uses well-researched, safe, and fast-acting drugs. These include: Propofol – Helps you sleep quickly and wakes you up smoothly. Also reduces nausea. Remifentanil – A short-acting painkiller that wears off fast, allowing quick recovery. Dexmedetomidine – Adds calmness, reduces anxiety, and maintains stable heart rate and breathing. These drugs are delivered precisely through an IV line — no mask, no gas, and in many cases, no breathing tube either. For patients, this method offers a dramatically improved experience, with no strong-smelling gases or uncomfortable masks. There is also no sore throat in many cases (especially when tubes are avoided). It aids faster return to alertness and normal activities. There are also lower chances of post-surgery dizziness or vomiting. This makes day-care surgeries, dental procedures, and even major surgeries easier and more pleasant. Is it available in India? Yes. TCI-TIVA is already in use in leading private and government hospitals, particularly in cities like Delhi, Mumbai, Chennai, Bengaluru, Hyderabad and all other metros and sub metro cities of India. Indian-made TCI devices have also entered the market, making the technology more cost-effective and accessible. Anaesthesiologists across India are being trained in this method, and more centres are adopting it every month. Is it the right option for everyone? In most cases, yes with all sex, age and weight patients. The decision however depends on: the type of surgery, the patient's medical history, the availability of TCI machines and the experience of the anaesthesia team. It is important to ask your doctor or anaesthesiologist about TCI-TIVA as an option before surgery. As a patient or family member, it is your right to be informed about all available and safe medical options. TCI-TIVA is not just a new technique — it is a safer, cleaner, and smarter way to experience anaesthesia. Just like you ask about the surgeon or the hospital, you can now ask: Can I have TCI-TIVA? TCI-TIVA represents the future of anaesthesia — not just for hospitals and doctors, but for you, the patient. It is cleaner for the planet, safer for your body, smarter for medical teams, and more comfortable for your surgical journey. This technology has already changed many operating rooms — and could soon change your surgical experience too. When it comes to your health, you deserve the best. And that means knowing and understanding the silent revolution taking place in the world of anaesthesia. (Dr. Tushar Chokshi is a privately practicing anaesthesiologist based in Vadodara, Gujarat. chokshitushar@
